VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

123 hedge funds and large institutions have $770M invested in Viridian Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 36 reducing their positions, and 18 closing their positions.

Holders
123
Holders Change
-5
Holders Change %
-3.91%
% of All Funds
1.96%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
14
Increased
55
Reduced
36
Closed
18
Calls
$133K
Puts
$1.17M
Net Calls
-$1.04M
Net Calls Change
+$5.87M

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$45.5M
2
PBA
2
Paradigm Biocapital Advisors
New York
$56.5M
3
B
3
Braidwell
Connecticut
$26.6M
4
EP
4
Eversept Partners
New York
$6.8M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$6.74M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
PA
2
Perceptive Advisors
New York
$15.5M
3
ABG
3
Ally Bridge Group
New York
$0
4
WP
4
Woodline Partners
California
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$3.12M
Name Holding Trade Value Shares
Change 		Shares
Change %
EP
26
Eversept Partners
New York
$6.8M +$6.8M +443,270 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$6.74M +$6.74M +439,191 New
5VM
28
5AM Venture Management
California
$6.29M +$1.99M +130,000 +46%
Northern Trust
29
Northern Trust
Illinois
$6.16M -$64.4K -4,199 -1%
Goldman Sachs
30
Goldman Sachs
New York
$6.12M +$1.28M +83,723 +27%
PHS
31
PFM Health Sciences
California
$5.54M +$1.04M +67,690 +23%
Morgan Stanley
32
Morgan Stanley
New York
$5.12M +$4.05M +264,044 +379%
Charles Schwab
33
Charles Schwab
California
$4.8M +$3.03M +197,430 +171%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$4.59M +$3M +195,616 +189%
GTC
35
Ghost Tree Capital
New York
$4.22M +$537K +35,000 +15%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$4.02M +$280K +18,282 +7%
Fidelity Investments
37
Fidelity Investments
Massachusetts
$4.02M +$6.58K +429 +0.2%
MB
38
MPM BioImpact
Massachusetts
$3.92M – – –
ACP
39
Acuta Capital Partners
California
$3.44M -$5.65K -368 -0.2%
Wellington Management Group
40
Wellington Management Group
Massachusetts
$3.31M +$665K +43,349 +25%
KFO
41
Kopp Family Office
Minnesota
$3.29M – – –
Bank of America
42
Bank of America
North Carolina
$3.15M +$406K +26,472 +15%
Nuveen Asset Management
43
Nuveen Asset Management
Illinois
$3.12M -$3.42M -222,754 -52%
ECM
44
ExodusPoint Capital Management
New York
$2.68M -$500K -32,590 -16%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$2.12M -$59.4K -3,875 -3%
WMSA
46
Weiss Multi-Strategy Advisers
New York
$2.02M -$377K -24,580 -16%
Barclays
47
Barclays
United Kingdom
$2.02M -$1.93M -125,979 -49%
Citigroup
48
Citigroup
New York
$1.69M +$469K +30,564 +38%
SSA
49
Schonfeld Strategic Advisors
New York
$1.66M +$1.3M +84,670 +362%
HS
50
HighVista Strategies
Massachusetts
$1.61M -$61.5K -4,009 -4%
1
2
3 4 5